Anika Therapeutics, Inc. (ANIK)

NASDAQ: ANIK · Real-Time Price · USD

14.46

-0.33 (-2.23%)

At close: Jun 5, 2026, 4:00 PM EDT

14.48

+0.02 (0.14%)

After-hours: Jun 5, 2026, 4:15 PM EDT

Anika Therapeutics Ratios and Metrics

Market cap in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun '26 Jun 5, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Market Cap	192	133	237	332	433	517
Market Cap Growth	12.19%	-43.75%	-28.57%	-23.26%	-16.34%	-20.22%
Enterprise Value	177.38	100.19	205.67	289.37	375.39	442.28
Last Close Price	14.46	9.61	16.46	22.66	29.60	35.83
PE Ratio	-	-	-	-	197.33	127.96
Forward PE	62.87	53.39	39.19	-	-	-
PEG Ratio	6.30	4.60	4.60	-	-	161.40
PS Ratio	1.66	1.18	1.98	2.75	3.80	3.50
PB Ratio	1.44	0.93	1.54	1.57	1.52	1.80
P/TBV Ratio	1.54	0.96	1.57	1.57	1.53	1.83
P/FCF Ratio	185.43	30.60	-	-	-	159.01
P/OCF Ratio	29.77	11.93	43.92	-	98.19	61.62
EV/Sales Ratio	1.53	0.89	1.72	2.40	3.30	2.99
EV/EBITDA Ratio	-	-	68.10	19.21	20.67	18.90
EV/EBIT Ratio	-	-	-	342.86	102.29	169.13
EV/FCF Ratio	170.72	22.97	-	-	-	135.92
Debt / Equity Ratio	0.18	0.17	0.16	0.12	0.10	0.07
Debt / EBITDA Ratio	-	-	7.95	1.72	1.59	0.82
Debt / FCF Ratio	22.90	5.55	-	-	-	5.91
Net Debt / Equity Ratio	-0.13	-0.23	-0.20	-0.20	-0.20	-0.26
Net Debt / EBITDA Ratio	2.57	6.25	-10.47	-2.84	-3.17	-3.21
Net Debt / FCF Ratio	-16.58	-7.63	13.56	5.94	18.69	-23.09
Asset Turnover	0.63	0.57	0.51	0.39	0.33	0.41
Inventory Turnover	2.31	2.30	1.82	1.19	1.07	1.58
Quick Ratio	3.19	3.71	3.40	3.06	4.33	4.17
Current Ratio	4.46	4.72	4.88	5.26	6.07	5.66
Return on Equity (ROE)	-7.99%	-6.71%	-4.82%	-1.38%	0.77%	1.48%
Return on Assets (ROA)	-7.16%	-6.03%	-6.88%	-0.30%	0.54%	1.25%
Return on Invested Capital (ROIC)	-11.59%	-9.92%	-10.53%	-0.44%	0.81%	1.89%
Return on Capital Employed (ROCE)	-7.50%	-6.35%	-2.43%	0.30%	1.15%	0.81%
Earnings Yield	-	-	-	-	0.51%	0.78%
FCF Yield	0.54%	3.27%	-	-	-	0.63%
Buyback Yield / Dilution	3.24%	2.59%	-0.44%	0.89%	-1.05%	-2.90%
Total Shareholder Return	3.24%	2.59%	-0.44%	0.89%	-1.05%	-2.90%

SEC Filings: 10-K · 10-Q